Benzinga Pro data, MFA Financial (NYSE:MFA) reported Q1 sales of $63.05 million. Earnings fell to a loss of $82.91 million, resulting in a 287.9% decrease from last quarter.
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Mfa Financial Inc's (NYSE:MFA) short percent of float has risen 10.95% since its last report. The company recently reported that it has 8.89 million shares sold short, which is 2.33% of all regular shares that are available for trading.
What is a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
MFA Financial (NYSE:MFA) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.11 by 27.27 percent. This is unchanged from the same period last year.